NCT06508866

Brief Summary

The TACTIC-TAVI registry aims to collect information about a consecutive cohort of patients undergoing transcatheter aortic valve insertion. The registry is international, multi-centre and observational. The registry is planned to continue until the calculated sample size is achieved.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
490

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

1.9 years

First QC Date

July 15, 2024

Last Update Submit

July 19, 2024

Conditions

Keywords

TAVIPacemakeraortic stenosis

Outcome Measures

Primary Outcomes (1)

  • Prediction of new requirement for permanent pacemaker after TAVI

    The primary focus of the registry is evaluating which patient characteristics and conduction disturbances may help to predict the new requirement for permanent pacemaker after TAVI.

    0-24 months

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study is a retrospective and prospective registry aiming to observe intra-procedural conduction disturbances in patients undergoing TAVI for severe aortic stenosis. Patients will have no alteration to standard post-procedural management and will their have usual follow-up. There are four key time points: 1) pre-procedure 2) intra-procedure 3) post-procedure 4) discharge. The electrocardiogram will be assessed at timepoints 1-3 and requirement for permanent pacemaker insertion by timepoint 4.

You may qualify if:

  • Patients successfully undergoing transcatheter aortic valve implantation for native severe aortic stenosis.

You may not qualify if:

  • Presence of previously implanted permanent cardiac pacemaker.
  • Valve-in-valve procedures.
  • No pre-procedural electrocardiogram is available.
  • No pre-procedural contrast CT TAVI is available.
  • Enrollment in another clinical trial.
  • Patients aged less than 18 years old.
  • Patients who do not consent for their data to be included in the registry.
  • Failed transcatheter aortic valve deployment. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituo Clinico Humanitas

Rozzano, Milano, 20089, Italy

RECRUITING

MeSH Terms

Conditions

Aortic Valve Stenosis

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Officials

  • Antonio Mangieri, MD

    Humanitas Research Horspital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antonio Mangieri, MD

CONTACT

Ottavia Cozzi, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2024

First Posted

July 18, 2024

Study Start

February 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Locations